Rutgers Cancer Institute of NJ

New Brunswick, New Jersey 08901

Use our guide to learn which trials are right for you!

We've found
3 trials
at this facility
Clinical Trial
Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)
Status: Enrolling, Phase II
Updated: 12/31/1969
Rutgers Cancer Institute of NJ
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of PTC299 in Relapsed/Refractory Acute Leukemias
Status: Enrolling, Phase I
Updated: 12/31/1969
Rutgers Cancer Institute of NJ
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Rutgers Cancer Institute of NJ
mi
from
New Brunswick, NJ
Click here to add this to my saved trials